Teva Completes Amendment to $10.9B of Credit Facilities
Teva Pharmaceutical Industries amended its USD and JPY term loan and revolving credit facilities of $5.0 billion and $1.4 billion, respectively and a $4.5 billion revolver.
September 21, 2017
Teva Pharmaceutical
Sam Nickerson